The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

14 articles for M Peters


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties.EBI
Dart Neuroscience
Design and Synthesis of Novel and Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders.EBI
Dart Neuroscience
 
Dopamine receptor binding properties of some 2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols with non-aromatic substituents in the 5-positionEBI
TBA
Discovery of IRAK4 Inhibitors EBI
Bayer
Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.EBI
Eli Lilly
Azetidine-based selective glycine transporter-1 (GlyT1) inhibitors with memory enhancing properties.EBI
Dart Neuroscience
Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis.EBI
Bayer
Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties.EBI
Dart Neuroscience
1-cyano-pyrrolidine derivatives as DUB inhibitorsBDB
Mission Therapeutics
Triazolyl pyrimidinone compounds as PDE2 inhibitorsBDB
Merck Sharp & Dohme
Dihydroxy aromatic heterocyclic compoundBDB
Takeda Pharmaceutical
Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.BDB
Shaoyang University
Compounds for inhibiting the interaction of BCL2 with binding partnersBDB
Novartis
Quinoline derivatives and MELK inhibitors containing the sameBDB
Oncotherapy Science